Avadel Pharmaceuticals PLC
Drug Manufacturers - Specialty & Generic
Healthcare
AVDL
96.60 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
16.02
52 week high
16.30
high
16.05
52 week low
0.00
low
15.72
growth
17.99 %
previous Close
16.00
P/E ratio
market cap
1.08 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
0.00 %
9.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top